SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7923016
Source:
http://linkedlifedata.com/resource/pubmed/id/7923016
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0205282
,
umls-concept:C0280100
,
umls-concept:C0282460
,
umls-concept:C1521725
pubmed:issue
9
pubmed:dateCreated
1994-11-10
pubmed:abstractText
5-Fluorouracil (5-FU) activity for various carcinomas of adults has been enhanced through the synergistic effect of leucovorin. Few pediatric studies of 5-FU in pediatric patients have been previously reported.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA 21765
,
http://linkedlifedata.com/resource/pubmed/grant/CA 23099
,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA 32613
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-543X
pubmed:author
pubmed-author:BowmanL CLC
,
pubmed-author:DouglassE CEC
,
pubmed-author:FOXJ PJP
,
pubmed-author:HoughtonJ AJA
,
pubmed-author:HowlettNN
,
pubmed-author:MeyerW HWH
,
pubmed-author:MounceKK
,
pubmed-author:PopSS
,
pubmed-author:PrattC BCB
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2593-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:7923016-Adolescent
,
pubmed-meshheading:7923016-Carcinoma
,
pubmed-meshheading:7923016-Child
,
pubmed-meshheading:7923016-Child, Preschool
,
pubmed-meshheading:7923016-Colorectal Neoplasms
,
pubmed-meshheading:7923016-Drug Administration Schedule
,
pubmed-meshheading:7923016-Drug Synergism
,
pubmed-meshheading:7923016-Female
,
pubmed-meshheading:7923016-Fluorouracil
,
pubmed-meshheading:7923016-Humans
,
pubmed-meshheading:7923016-Infant
,
pubmed-meshheading:7923016-Leucovorin
,
pubmed-meshheading:7923016-Male
,
pubmed-meshheading:7923016-Neoplasms
,
pubmed-meshheading:7923016-Osteosarcoma
,
pubmed-meshheading:7923016-Sarcoma, Ewing
,
pubmed-meshheading:7923016-Treatment Outcome
pubmed:year
1994
pubmed:articleTitle
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors.
pubmed:affiliation
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II